RankAlpha logo
Back to Rankings

CADL

Candel TherapeuticsD
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
View Chart
Current thesis
The pivotal prostate result, September biomarker update and a timely BLA could improve the path toward a 2027 launch [#SEC-8K-2026-08-13] [#IR-2026-09-30] (company update).
Posture
Defensive
Lead driver
Sentiment
What changed
Sentiment remains the lead driver in the composite, 7D delta -32.7.
What can break
BLA timing, completeness, FDA acceptance and eventual approval are uncertain.
Momentum
13
Value
41
Sentiment
65
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $8.50 · Bull $13.50 · Bear $4.50Analysis 2026-10-17; returns require an exact persisted reference.
Data freshness
Prices
Unavailable: Price unavailable
Fundamentals
As of 2026-10-23 • Vendor: Data Vendor v1
Scores
As of 2026-10-23 • Model: HYBRID_IC_RP
AI Memo
As of 2026-10-17 • Model: RankAlpha Sentiment Codex
Investment thesis
As of 2026-10-23

Grade is the composite factor band; factor scores use a 0–100 scale. Confidence describes evidence quality, not a probability of return. Score date: 2026-10-23. Definitions

Supporting evidence
What
Grade D · Defensive
Confidence Medium · Net Neutral
Target $21.75
Why
Momentum13 · Δ7d -28.1
Value41 · Δ7d -0.1
Sentiment65 · Δ7d -32.7
So what
Weak posture (Net Neutral). Prioritize risk control and patience.

Confirming evidence

  • • Sentiment remains the lead driver in the composite, 7D delta -32.7.

Contradictions & invalidation

  • • BLA timing, completeness, FDA acceptance and eventual approval are uncertain.
  • • Clinical-stage cash burn and potential launch spending could increase financing or dilution risk despite the company's stated runway [#SEC-8K-2026-08-13].
  • • A filing delay, regulatory request for additional evidence, or launch-readiness costs could outweigh the clinical signal.

Catalyst clock

2026-11-07

SITC program-data presentations

Lead driver: Sentiment · See AI snapshot
Momentum
13
8% active weight
Current posture
7d trendSoftening
Δ7d
-28.1
Δ21d
-47.8
Value
41
47% active weight
Current posture
7d trendFlat
Δ7d
-0.1
Δ21d
-0.4
Sentiment
65
45% active weight
Current posture
7d trendFlat
Δ7d
-32.7
Δ21d
-15.4
Why this grade

Composite grade D. Momentum 13.1 / Value 40.6 / Sentiment 64.9

Scenario snapshot

Scenario probability is memo-authored likelihood, not forecast certainty. Targets belong to the analysis dated 2026-10-17. Scenario method

B+
Bull case
25%
Probability
Target price
$13.50
Analysis reference price unavailable
Analysis 2026-10-17 · RankAlpha Sentiment Codex
Most likely
B
Base case
50%
Probability
Target price
$8.50
Analysis reference price unavailable
Analysis 2026-10-17 · RankAlpha Sentiment Codex
B-
Bear case
25%
Probability
Target price
$4.50
Analysis reference price unavailable
Analysis 2026-10-17 · RankAlpha Sentiment Codex
Fundamentals (TTM)
As of 2026-10-23
Market Cap
$614.44M
Beta
-0.93
Shares Out
76.52M
P/E (TTM) · Derived
-11.1
P/S (TTM)
-
P/FCF (TTM) · Derived
-8.71
Rev YoY
-100.0%
EPS YoY
+463.7%
Gross Margin
-3654.8%
Op Margin
-
Net Debt
-$70.7M
Current Ratio
16.09
As of 2026-10-23 • Updated nightlySource: Internal modelMethods & Data